NCT05165043

Brief Summary

The patients who conducted position change due to massive EGVB resulting in poor visualization in the stomach were included. Those with incomplete information were excluded. The patients were characterized in terms of age, sex, causes of liver cirrhosis, adverse events (AEs) during position change, additional findings after body position change, treatment regimens and follow-up information.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
11

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 29, 2021

Completed
22 days until next milestone

First Posted

Study publicly available on registry

December 21, 2021

Completed
9 days until next milestone

Study Start

First participant enrolled

December 30, 2021

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 5, 2022

Completed
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2022

Completed
Last Updated

December 21, 2021

Status Verified

December 1, 2021

Enrollment Period

6 days

First QC Date

November 29, 2021

Last Update Submit

December 20, 2021

Conditions

Emergency Hemostasis

Keywords

Complications of cirrhosisVariceal bleedingPosition changeEmergency hemostasisRebleeding

Outcome Measures

Primary Outcomes (2)

  • Incidence of successful hemostasis

    non-rebleeding within 5 days after treatment

    within 5 days

  • Incidence of rebleeding

    early rebleeding

    within 5 days

Study Arms (1)

PC group

The patients who conducted position change due to massive EGVB resulting in poor visualization in the stomach were included. The patients were characterized in terms of age, sex, causes of liver cirrhosis, adverse events (AEs) during position change, additional findings after body position change, treatment regimens and follow-up information. During position changing procedure, endoscopist withdrew the gastroscope from the stomach and patients changed from the left lateral position to the right lateral position with the help of the nurses. Then endoscopist reinserted the gastroscope into the stomach and tried to detect the addition varices after position change. Bleeding varices were treated by injection of N-butyl-Cyanoacrylate glue (glub B or Beltran, Compex) or/and Lauromacrogol (Shanxi, Tianyu).

Procedure: position change

Interventions

position changePROCEDURE

The patients who conducted position change due to massive EGVB resulting in poor visualization in the stomach were included,patients changed from the left lateral position to the right lateral position.

PC group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The patients who conducted position change due to massive EGVB resulting in poor visualization in the stomach were included.

You may qualify if:

  • conducted position change due to massive EGVB resulting in poor visualization in the stomach

You may not qualify if:

  • incomplete information

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ningbo first hospital

Ningbo, Zhejiang, 315000, China

Location

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 29, 2021

First Posted

December 21, 2021

Study Start

December 30, 2021

Primary Completion

January 5, 2022

Study Completion

January 30, 2022

Last Updated

December 21, 2021

Record last verified: 2021-12

Locations

CN(1)